{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:22:16Z","timestamp":1789996936410,"version":"4.0.1"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Priority Program Sleep and Health of the University of Zurich"},{"name":"NIHR Biomedical Research Centre Oxford"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respirology"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:title>\n<jats:styled-content style=\"fixed-case\">ABSTRACT<\/jats:styled-content>\n<\/jats:title><jats:sec><jats:title>Background and objective<\/jats:title><jats:p>Obstructive sleep apnoea (<jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>) is associated with cardiovascular disease. Intermittent hypoxia, endothelial dysfunction and adipose tissue\u2010mediated inflammation have all been linked to cardiovascular disease in <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>. We therefore explored the effect of <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content> on relevant associated blood markers: adrenomedullin (<jats:styled-content style=\"fixed-case\">ADM<\/jats:styled-content>), endocan, endothelin\u20101 (<jats:styled-content style=\"fixed-case\">ET<\/jats:styled-content>\u20101), resistin and vascular endothelial growth factor (VEGF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>, established on and compliant with continuous positive airways pressure (<jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>) therapy for &gt;1\u2009year were included from three randomized controlled trials, conducted at two centres. Patients were randomized to either continued therapeutic <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> or sham <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> withdrawal) for 2 weeks. Blood markers were measured at baseline and at 14 days and the treatment effect between sham <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> and therapeutic <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> was analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 109 patients were studied (therapeutic <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> <jats:italic>n<\/jats:italic>\u2009=\u200954, sham <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> <jats:italic>n<\/jats:italic>\u2009=\u200955). Sham <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> was associated with a return of <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content> (between\u2010group difference in oxygen desaturation index (<jats:styled-content style=\"fixed-case\">ODI<\/jats:styled-content>) 36.0\/h, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 29.9\u201342.2, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Sham <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> was associated with a reduction in <jats:styled-content style=\"fixed-case\">ADM<\/jats:styled-content> levels at 14 days (\u221226.0\u2009pg\/<jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> \u221247.8 to \u22124.3, <jats:italic>P<\/jats:italic>\u2009=\u20090.02), compared to therapeutic <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content>. Return of <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content> was not associated with changes in endocan, <jats:styled-content style=\"fixed-case\">ET<\/jats:styled-content>\u20101, resistin or VEGF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Whilst <jats:styled-content style=\"fixed-case\">CPAP<\/jats:styled-content> withdrawal was associated with return of <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content>, it was associated with an unexpected significant reduction in the vasodilator <jats:styled-content style=\"fixed-case\">ADM<\/jats:styled-content> and not with expected increases in hypoxia\u2010induced markers, markers of endothelial function or resistin. We propose that the vascular effects occurring in <jats:styled-content style=\"fixed-case\">OSA<\/jats:styled-content> may be brought about by other mechanisms, perhaps partly through a reduction in <jats:styled-content style=\"fixed-case\">ADM<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/resp.12946","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T09:27:44Z","timestamp":1479461264000},"page":"793-799","source":"Crossref","is-referenced-by-count":19,"title":["Effect of <scp>OSA<\/scp> on hypoxic and inflammatory markers during <scp>CPAP<\/scp> withdrawal: <scp>F<\/scp>urther evidence from three randomized control trials"],"prefix":"10.1111","volume":"22","author":[{"given":"Chris D.","family":"Turnbull","sequence":"first","affiliation":[{"name":"Oxford Centre for Respiratory Medicine Oxford University Hospitals NHS Foundation Trust  Oxford UK"},{"name":"NIHR Oxford Biomedical Research Centre University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina A.","family":"Rossi","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Sleep Disorders Center University Hospital of Zurich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Santer","sequence":"additional","affiliation":[{"name":"NIHR Oxford Biomedical Research Centre University of Oxford  Oxford UK"},{"name":"Department of Physiology, Anatomy and Genetics University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther I.","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Sleep Disorders Center University Hospital of Zurich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Stradling","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine Oxford University Hospitals NHS Foundation Trust  Oxford UK"},{"name":"NIHR Oxford Biomedical Research Centre University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayia","family":"Petousi","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine Oxford University Hospitals NHS Foundation Trust  Oxford UK"},{"name":"Nuffield Department of Medicine University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Kohler","sequence":"additional","affiliation":[{"name":"Division of Pulmonology and Sleep Disorders Center University Hospital of Zurich  Zurich Switzerland"},{"name":"Center for Integrative Human Physiology University of Zurich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,11,18]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304293281704"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.9.736"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07445-7"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71141-7"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201106-0964OC"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0179"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.145"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2006.00498.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2007.01402.x"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917010-00010"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.5665\/sleep.4180"},{"key":"e_1_2_7_13_1","first-page":"50","article-title":"Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity","volume":"74","author":"Peled N","year":"2007","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.04.009"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.09.005"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.09.030"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.15.117"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0003319715590558"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.12.029"},{"key":"e_1_2_7_20_1","first-page":"377","article-title":"Resistin is closely related to systemic inflammation in obstructive sleep apnea","volume":"76","author":"Yamamoto Y","year":"2008","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00023215"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12798"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.19.6.555"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1992.72.5.1978"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.050"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201406-1149LE"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2015_114"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00629.2014"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199805000-00003"},{"key":"e_1_2_7_30_1","first-page":"14","article-title":"Adrenomedullin and cardiovascular diseases","volume":"1","author":"Wong HK","year":"2012","journal-title":"JRSM Cardiovasc. Dis."},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2869.2007.00589.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.09.047"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12573"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2014.03.007"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783X-14-S4-255"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-80"},{"key":"e_1_2_7_37_1","first-page":"CR510","article-title":"Resistin levels in patients with obstructive sleep apnoea syndrome \u2013 the link to subclinical inflammation?","volume":"10","author":"Harsch IA","year":"2004","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."}],"container-title":["Respirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fresp.12946","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fresp.12946","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/resp.12946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T14:47:59Z","timestamp":1696171679000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/resp.12946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,18]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1111\/resp.12946"],"URL":"https:\/\/doi.org\/10.1111\/resp.12946","archive":["Portico"],"relation":{},"ISSN":["1323-7799","1440-1843"],"issn-type":[{"value":"1323-7799","type":"print"},{"value":"1440-1843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,18]]}}}